Becaplermin
Links shared publicly online about this topic
European Medicines Agency Recommends Contraindication For Regranex In Patients With Any Pre-Existing Cancer
medicalnewstoday.com — “Following a review of the available data on a possible risk of cancer in patients using Regranex (becaplermin), from Janssen-Cilag International N.V., the European Medicines Agency has concluded t” View full resource at medicalnewstoday.com
Most Recently Shared on February 19, 2010 at 2:08 pm By:
European Medicines Agency Recommends Contraindication For Regranex In Patients With Any Pre-Existing Cancer http://mnt.to/3xPV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Skin Cancer
The latest melanoma and skin cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
